Expression of integrins and extracellular matrix proteins at the maternal-fetal interface during tubal implantation.
Investigation of the expression pattern of integrins and their extracellular matrix (ECM) ligands in trophoblasts at the maternal-fetal interface during tubal pregnancy may aid better understanding of the adhesion and invasion of acceptable maternal endometrium by trophoblast cells at the very early stage of human gestation. In this study, spatial and temporal alterations of integrins and ECM ligands were examined in specimens of tubal pregnancies during weeks 3-9 of gestation. In situ hybridization and immunohistochemistry revealed that relatively high levels of integrin alpha(1), beta(1), alpha(5) subunits and heterdimer alpha(5)beta(1) as well as ECM ligands, were displayed in trophoblast cells as early as weeks 3-4 of gestation. Expression peaked during weeks 5-7 and then, with the exception of integrin alpha(1), which remained high, declined slightly up to weeks 8-9 of gestation. Immunoreactive fibronectin, laminin and type IV collagen were detected in column cytotrophoblastic cells (CTB) and some invasive extravillous cytotrophoblast (EVCT) cells and the alterations were coincident with those of the corresponding integrin receptors in EVCT cells. Laminin was strongly stained in EVCT cells that had invaded maternal blood vessels and deep into the interstitium. Maternal epithelial, endothelial and stromal cells also expressed these integrins and ECM ligands. The results indicate their involvement in mediating the adhesion of trophoblasts to the epithelium of the maternal Fallopian tube. The upregulated expression of these molecules in column CTB and invasive EVCT cells may also facilitate the invasion of trophoblasts into the maternal interstitium. Moreover, trophoblasts possessed the potential for self-controlled adhesion and invasion and appear to reach peak invasive capability in the second month of tubal implantation.
Qin
L
L
State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100080, China.
Wang
Y L
YL
Bai
S X
SX
Xiao
Z J
ZJ
Herva
R
R
Piao
Y S
YS
D024141:Collagen Type IV / Q000032:analysis; D010064:Embryo Implantation; D042783:Endothelial Cells / Q000737:chemistry; D004847:Epithelial Cells / Q000737:chemistry; D016326:Extracellular Matrix Proteins / Q000032:analysis*; D005187:Fallopian Tubes / Q000737:chemistry*; D005260:Female; D005353:Fibronectins / Q000032:analysis; D005865:Gestational Age; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D039423:Integrin alpha1 / Q000032:analysis; D039482:Integrin alpha5 / Q000032:analysis; D019012:Integrin beta1 / Q000032:analysis; D016023:Integrins / Q000032:analysis*; D007797:Laminin / Q000032:analysis; D011247:Pregnancy; D011274:Pregnancy, Tubal / Q000378:metabolism*; D014327:Trophoblasts / Q000737:chemistry*
D024141:Collagen Type IV; D016326:Extracellular Matrix Proteins; D005353:Fibronectins; D039423:Integrin alpha1; D039482:Integrin alpha5; D019012:Integrin beta1; D016023:Integrins; D007797:Laminin